Lawingan, Mary Ann .
HRN: 21-48-72 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/31/2022
CEFUROXIME 750MG (VIAL)
05/31/2022
06/06/2022
IVT
260mg
Q8
Sepsis
Waiting Final Action